Cardiology & Electrophysiology Symposium


Concepts & Controversies         

Thank you for your interest in Dignity Health Heart and Vascular Institute of Greater Sacramento's 30th Annual Cardiology & Electrophysiology CME Symposium 2021. 

Event Details 

 

Saturday, October 16, 2021
7:30 a.m. to 12:10 p.m.
via Zoom 

REGISTRATION IS NOW OPEN!

7:30 a.m. Exhibitors 

8:00 a.m. Welcome  

12:10 p.m. Closing Remarks/Adjourn


Our featured presentations will include:

TAVR for Everyone? Not Necessarily

Peter Block, MD, FACC, MSCAI

Mitral Regurgitation: Are Mitral Valve Transcatheter Edge to Edge Repair (TEER) Techniques the Answer?

Peter Block, MD, FACC, MSCAI

Should Ablation be First Line Therapy for Atrial Fibrillation?

Edward Gerstenfeld, MD

Arrhythmias in Mitral Valve Prolapse - When to Worry

Edward Gerstenfeld, MD

What medications and devices are beneficial for patients with HfrEf?

Wayne Levy, MD, FACC

What medications and devices are beneficial for patients with HFpEF?

Wayne Levy, MD, FACC

What is New in Coronary Interventions: 2021

Richard Heuser, MD, FACC, FACP, FESC, MSCAI

New Treatments in Peripheral Vascular Disease 

Richard Heuser, MD, FACC, FACP, FESC, MSCAI


Objectives:

At the conclusion of our program, participants should be able to implement the following changes to their professional practice:

  • Identify patients who would benefit from Transcather Aortic Valve Replacement (TAVR) versus surgery
  • Recognize the limits and outcomes of transcatheter mitral therapy use
  • Decide when it is appropriate to recommend catheter ablation as first-line therapy for atrial fibrillation
  • Risk stratify patients with Mitral Valve Prolapse (MVP) and ventricular ectopy
  • Understand which medications and devices have a meaningful reduction in mortality in patients with heart failure with a reduced ejection fraction (HFrEF)
  • Understand the importance of volume management in keeping heart failure with preserved ejection fraction (HFpEF) patients out of the hospital
  • Have a thoughtful approach to treating Coronary Microvascular Disease (MVD), chronic total occlusion (CTO), and left main/stent
  • Recognize the importance and treatment strategy in Critical Limb Ischemia (CLI)
     

Chairpersons:

Scott B. Baron, MD, FACC, FSCAI

Symposium Chairman

Director, Cardiac Emergency Services

Dignity Health Mercy San Juan Medical Center

Clinical Professor of Medicine

California Northstate University School of Medicine

P. Gearoid O’Neill, MD, FACC, FHRS

Symposium Co-Chairman

Director, Cardiac Electrophysiology

Dignity Health Mercy General Hospital

Joyce Higley, RD, MHA

Senior Director

Dignity Health Heart and Vascular Institute of Greater Sacramento

Anu LoCricchio, RN, MBA

Director, Cardiovascular Services

Dignity Health Heart and Vascular Institute of Greater Sacramento

Faculty:

Peter Block, MD, FACC, MSCAI

Professor Emeritus

Emory University School of Medicine

Atlanta, Georgia

Edward Gerstenfeld, MD

Professor of Medicine

Chair of Cardiac Electrophysiology

University of California, San Francisco School of Medicine

San Francisco, California

Wayne Levy, MD, FACC

Professor of Medicine

Cardiology University of Washington Heart Institute 

Seattle Washington

Richard Heuser, MD, FACC, FACP, FESC, MSCAI

Vascular Heart and Lung Associates 

Mesa, Arizona

REGISTER HERE

 

Accreditation Statement:

Dignity Health Sacramento is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

Credit Designation:

Dignity Health Sacramento designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Provider Designee: Monica Bourke, MSN, RN